The safety of electroconvulsive therapy (ECT) in patients with deep brain stimulation (DBS) has not been established. Cases reported had no adverse events, but DBS was withheld throughout the weeks of the ECT course. The authors report the first case of temporary interruption of DBS only during the minutes of each outpatient ECT.

Volume 23
Issue 2

Spring 2011
Pages 194-197

Metrics

Dr. Ducharme, Dr. Flaherty, and Dr. Seiner have no disclosure or conflict of interest related to this topic. Dr. Dougherty's research has been funded by NIMH, NARSAD, TSA, and OCF. He has received honoraria, consultation fees, and/or royalties from Wyeth, Jazz Pharmaceuticals, Bristol-Myers Squibb, Medtronic, Eli Lilly, Northstar, McNeil, Brand Ideas, and Reed Elsevier. He has also participated in research funded by Medtronic, Cyberonics, Eli Lilly, McNeil and Northstar.

Dr. Morales is the inventor on a patent application owned by McLean Hospital that is related to the subject matter of this manuscript, but this application is still pending and is not licensed to any for-profit entity, and Dr. Morales receives no income or revenues attributable to that patent application. Dr. Morales is the PI on a clinical trial agreement that is not yet executed, but is under negotiation with Brainsway, Inc., and McLean Hospital.

PDF download

History

Received 1 June 2010

Revised 1 August 2010

Accepted 3 August 2010

Published online 1 April 2011

Published in print 1 April 2011

Sign In

Change Password

Your password must have 6 characters or more:

Password Changed Successfully

Create your account

Forget yout Password?

Forgot your Username?

Temporary Interruption of Deep Brain Stimulation for Parkinson's Disease During Outpatient Electroconvulsive Therapy for Major Depression: A Novel Treatment Strategy

Abstract